Literature DB >> 31143577

Main Symptom that Led to Medical Evaluation and Diagnosis of Vestibular Schwannoma and Patient-Reported Tumor Size: Cross-sectional Study in 1,304 Patients.

Maria Peris-Celda1, Christopher S Graffeo1, Avital Perry1, Panagiotis Kerezoudis1, Nicole M Tombers2, Matthew L Carlson2, Michael J Link1.   

Abstract

Objectives  Although vestibular schwannomas (VS) are known to cause cranial nerve deficits, cerebellar symptoms, and hydrocephalus, the role of these symptoms as the key driver of presentation from the patient's perspective has not been described. Our objective was to survey a large, retrospective VS cohort to document the patient-reported principal initial symptom, and self-reported tumor size, and to study trends in VS patient presentation. Methods  Patients diagnosed with VS at our tertiary referral center and belonging to the Acoustic Neuroma Association (ANA) answered a questionnaire between 2015 and 2017. Demographic data, self-reported tumor size, and symptomatology were analyzed. Results  1,304 patients completed the questionnaire. Tumors were diagnosed from 1966 to 2017 at a mean 51.8 years (range: 8-86 years); 66% were female, and 1.1% had confirmed neurofibromatosis type 2 (NF2). Tumor size was reported using a 6-point scale: 0 to 1 cm (22.9%), 1 to 2 cm (28.7%), 2 to 3 cm (20.5%), 3 to 4 cm (10%), greater than 4 cm (7.2%), and unknown (10.6%). Hearing loss was the most common symptom that led to diagnosis (51.5%), followed by dizziness (17%), tinnitus (11.2%), and incidental diagnosis (10.2%); a fraction that has increased significantly in the last decade ( p  = 0.022). Larger tumors and NF2 were significantly associated with young age ( p  < 0.001). Conclusion  Our large-scale questionnaire-driven review of 1,304 patients confirms that VS presentations are stereotypical, with most individuals recalling hearing loss, dizziness, or tinnitus as their chief complaint. Many tumors were incidentally diagnosed; an expanding population, attributable to increased access to magnetic resonance imaging (MRI). Large tumors were significantly more prevalent among younger patients at diagnosis, excluding NF2 patients, suggesting a more aggressive tumor biology that remains incompletely understood.

Entities:  

Keywords:  acoustic neuroma; dizziness; hearing loss; symptoms at presentation; vestibular schwannoma

Year:  2018        PMID: 31143577      PMCID: PMC6534738          DOI: 10.1055/s-0038-1675175

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  26 in total

1.  What is the real incidence of vestibular schwannoma?

Authors:  Mirko Tos; Sven-Eric Stangerup; Per Cayé-Thomasen; Tina Tos; Jens Thomsen
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2004-02

2.  True incidence of vestibular schwannoma?

Authors:  Sven-Eric Stangerup; Mirko Tos; Jens Thomsen; Per Caye-Thomasen
Journal:  Neurosurgery       Date:  2010-11       Impact factor: 4.654

3.  Improved preservation of hearing and facial nerve function in vestibular schwannoma surgery via the retrosigmoid approach in a series of 200 patients.

Authors:  Madjid Samii; Venelin Gerganov; Amir Samii
Journal:  J Neurosurg       Date:  2006-10       Impact factor: 5.115

4.  Untreated vestibular schwannomas: vertigo is a powerful predictor for health-related quality of life.

Authors:  Erling Myrseth; Per Møller; Tore Wentzel-Larsen; Frederik Goplen; Morten Lund-Johansen
Journal:  Neurosurgery       Date:  2006-07       Impact factor: 4.654

5.  Acoustic neuroma observation associated with an increase in symptomatic tinnitus: results of the 2007-2008 Acoustic Neuroma Association survey.

Authors:  Jamie J Van Gompel; Jaymin Patel; Chris Danner; A Nanhua Zhang; A A Samy Youssef; Harry R van Loveren; Siviero Agazzi
Journal:  J Neurosurg       Date:  2013-06-21       Impact factor: 5.115

6.  Incidence of vestibular schwannoma and neurofibromatosis 2 in the North West of England over a 10-year period: higher incidence than previously thought.

Authors:  D Gareth R Evans; Anthony Moran; Andrew King; S Saeed; Nihal Gurusinghe; Richard Ramsden
Journal:  Otol Neurotol       Date:  2005-01       Impact factor: 2.311

7.  Conservative management of acoustic neuroma: a meta-analysis and proposed treatment algorithm.

Authors:  Eric E Smouha; Michael Yoo; Kristi Mohr; Raphael P Davis
Journal:  Laryngoscope       Date:  2005-03       Impact factor: 3.325

8.  Increasing annual incidence of vestibular schwannoma and age at diagnosis.

Authors:  Sven-Eric Stangerup; Mirko Tos; Per Caye-Thomasen; Tina Tos; Mads Klokker; Jens Thomsen
Journal:  J Laryngol Otol       Date:  2004-08       Impact factor: 1.469

9.  Patient perception of comorbid conditions after acoustic neuroma management: survey results from the acoustic neuroma association.

Authors:  John M Ryzenman; Myles L Pensak; John M Tew
Journal:  Laryngoscope       Date:  2004-05       Impact factor: 3.325

10.  Incidence of vestibular schwannoma and incidental findings on the magnetic resonance imaging and computed tomography scans of patients from a direct referral audiology clinic.

Authors:  B Y W Wong; R Capper
Journal:  J Laryngol Otol       Date:  2012-05-14       Impact factor: 1.469

View more
  3 in total

1.  Koos grade IV vestibular schwannomas: considerations on a consecutive series of 60 cases-searching for the balance between preservation of function and maximal tumor removal.

Authors:  Luciano Mastronardi; Alberto Campione; Fabio Boccacci; Carlo Giacobbo Scavo; Ettore Carpineta; Guglielmo Cacciotti; Raffaelino Roperto; Albert Sufianov; Ali Zomorodi
Journal:  Neurosurg Rev       Date:  2021-02-18       Impact factor: 3.042

2.  Microsurgical treatment of symptomatic vestibular schwannomas in patients under 40: different results before and after age of 30.

Authors:  Luciano Mastronardi; Alberto Campione; Guglielmo Cacciotti; Ettore Carpineta; Carlo Giacobbo Scavo; Raffaele Roperto; Giovanni Stati; Albert A Sufianov; Karl Schaller
Journal:  Neurosurg Rev       Date:  2021-08-17       Impact factor: 3.042

3.  Hearing Outcome After Linear Accelerator-Based Radiotherapy for Vestibular Schwannomas: A Retrospective Analysis of a Single Center.

Authors:  Dominique Valérie Clarence de Jel; Ernst J Smid; Tristan P C van Doormaal; Hans G X M Thomeer
Journal:  J Int Adv Otol       Date:  2021-09       Impact factor: 1.017

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.